Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -

Clinical trial NCT00216658 · COMPLETED

Trial details

NCT number: NCT00216658
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pain, Intractable

Start date: 2004-12-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.